EGFR/HER2-IN-14 (Compd 46) is an inhibitor of mutant EGFR/HER2s which are resistant to other drugs. EGFR/HER2-IN-14 can be used for cancer research[1].
References
[1] John H, et al. Inhibitors of egfr or her2 and methods of use. WO2024073745A1. 2024-04-04
